| Literature DB >> 32854781 |
Meng-Meng Yang1, Lu Wang2, Yu Zhang2, Rui Yuan2, Yan Zhao1, Jie Hu1, Fei-Hu Zhou1, Hong-Jun Kang3.
Abstract
BACKGROUND: Heat stroke (HS) is a serious, life-threatening disease. However, there is no scoring system for HS so far. This research is to establish a scoring system that can quantitatively assess the severity of exertional heat stroke (EHS).Entities:
Keywords: Effectiveness of evaluation; Exertional heat stroke; Prognosis; Scoring system
Mesh:
Year: 2020 PMID: 32854781 PMCID: PMC7453553 DOI: 10.1186/s40779-020-00269-1
Source DB: PubMed Journal: Mil Med Res ISSN: 2054-9369
The screening parameters for EHSS
| Classification | Parameters | |||||
|---|---|---|---|---|---|---|
| Vital signs | T | MAP | RR | HR | ||
| Central nervous system | GCS | |||||
| Blood gas analysis | PH | SaO2 | HCO3− | Lac | ||
| Routine blood test | Hb | WBC | N% | PLT | ||
| Cardiac function | BNP | CK-MB | TnI | LDH | ||
| Hepatic function | ALT | AST | TBIL | DBIL | ALB | |
| Kidney function | Cr | BUN | ||||
| Rhabdomyolysis | Mb | uMb | CK | |||
| Coagulation | PT | APTT | TT | Fib | D-D | FDP |
| Inflammation markers | CRP | IL-6 | PCT | |||
| Electrolyte | K+ | Na+ | Cl− | Ca2+ | ||
| Metabolic parameters | Glu | |||||
| Gastrointestinal function | AGI(I—IV) | |||||
T Temperature, MAP Mean arterial pressure, RR Respiratory rate, HR Heart rate, GCS Glasgow Coma Scale, SaO Oxygen saturation, Lac Lactate, Hb Hemoglobin, WBC White blood cell count, N Neutrophils, PLT Platelets, BNP Brain natriuretic peptide, CK-MB Creatine kinase isoenzymes, TnI Troponin I, LDH Lactate dehydrogenase, ALT Alanine transaminase, AST Aspartate transaminase, TBIL Total bilirubin, DBIL Direct bilirubin, ALB Albumin, Cr Creatinine, BUN Blood urea nitrogen, Mb Myoglobin, uMb uric myoglobin, CK Creatine kinase, PT Prothrombin time, APTT Activated part of the Prothrombin Time, TT Thrombin time, Fib Fibrinogen, D-D D-dimer, FDP Fibrin degradation products, CRP C-reactive protein, IL-6 Interleukin-6, PCT Procalcitonin, K Potassium, Na Sodium, Cl−. Chlorine, Ca Calcium, Glu Glucose, AGI Acute gastrointestinal injury
The demographics and baseline clinical data of the EHS patients for EHSS establishment and EHSS verification
| Variables | Total | Survival group | Nonsurvival group | |
|---|---|---|---|---|
| EHSS establishment ( | 90 | 69 | 21 | |
| Male [ | 84 (93.3) | 64 (92.8) | 20 (95.2) | 1.000 |
| Age [year, M(Q)] | 22 (19–32) | 22 (19–26.5) | 27 (20.5–37.5) | 0.066 |
| APACHE II score ( | 23.5 ± 8.6 | 20.7 ± 7.4 | 32.8 ± 4.7 | 0.048 |
| Vasoactive drugs [ | 25 (27.8) | 14 (20.3) | 11 (52.4) | 0.013 |
| Cooling effect [ | 32 (35.6) | 27 (39.1) | 5 (23.8) | 0.161 |
| EHSS verification ( | 80 | 62 | 18 | |
| Male [ | 72 (90.0) | 58 (93.5) | 14 (77.8) | 0.071 |
| Age [year, M(Q)] | 24 (20–30) | 25 (20.7–30.2) | 20.5 (19.7–27.2) | 0.146 |
| APACHE II score ( | 21.2 ± 7.3 | 18.9 ± 5.9 | 29.1 ± 6.4 | < 0.001 |
| Vasoactive drugs [ | 29 (36.3) | 17 (27.4) | 12 (66.7) | 0.002 |
| Cooling effect [ | 35 (43.8) | 29 (46.8) | 6 (33.3) | 0.312 |
EHSS Exertional Heat Stroke Score, APACHE II Acute Physiology and Chronic Health Evaluation II score, Cooling effect. Core body temperature dropped to 38.5 °C within 2 h after EHS onset
Comparison of demographics and baseline clinical data between the EHSS establishment group and the EHSS verification group
| Variables | Total ( | EHSS establishment group ( | EHSS verification group ( | |
|---|---|---|---|---|
| Male/Female | 156/14 | 84/6 | 72/8 | 0.430 |
| Age [year, M(Q)] | 22 (20–31) | 22 (19–32) | 24 (20–30) | 0.598 |
| APACHE II score ( | 22.4 ± 8.1 | 23.5 ± 8.6 | 21.2 ± 7.3 | 0.066 |
| Vasoactive drugs [ | 54 (31.8) | 25 (27.8) | 29 (36.3) | 0.236 |
| Cooling effect [ | 67 (39.4) | 32 (35.5) | 35 (43.8) | 0.275 |
| Death [ | 39 (22.9) | 21 (23.3) | 18 (22.5) | 0.897 |
EHSS. Exertional Heat Stroke Score; APACHE II. Acute Physiology and Chronic Health Evaluation II score; Cooling effect. Core body temperature dropped to 38.5 °C within 2 h after EHS onset
Univariate statistical analysis for screening EHSS parameters
| Parameters | Total ( | Survival group ( | Nonsurvival group ( | |
|---|---|---|---|---|
| T [°C,M(Q)] | 40.7 (40.0–41.2) | 40.5 (39.4–41.0) | 41 (40.5–42.0) | < 0.0001 |
| MAP (mmHg, | 76.2 ± 19.1 | 75.7 ± 17.5 | 77.8 ± 23.9 | 0.06 |
| RR [beats/min, M(Q)] | 26 (20–30) | 25 (20–30) | 30 (26–35) | 0.012 |
| HR (beats/min, | 123 ± 35 | 118 ± 36 | 138 ± 27 | 0.089 |
| GCS [score, M(Q)] | 5.0 (3.0–8.0) | 7.0 (3.5–9.0) | 3.0 (3.0–3.5) | < 0.0001 |
| pH [M(Q)] | 7.37 (7.27–7.39) | 7.37 (7.35–7.40) | 7.23 (7.23–7.27) | < 0.0001 |
| SaO2 [M(Q)] | 92 (91–98) | 92 (92–99) | 91 (88–92) | 0.007 |
| HCO3−(mmol/L, | 18.2 ± 4.8( | 19.5 ± 4.7( | 14.8 ± 3.4( | 0.429 |
| Lac [mmol/L, M(Q)] | 4.4 (3.6–7.3) | 4.4 (3.3–4.8) | 9.5 (8.0–10.5) | < 0.0001 |
| Hb [g/L, M(Q)] | 130.0 (118.0–138.0) | 130.0 (121.5–138.5) | 118.0 (99.5–139.0) | 0.058 |
| WBC (× 1012/L, | 14.4 ± 6.2 | 13.9 ± 5.4 | 16.0 ± 8.3 | 0.026 |
| N [%, M(Q)] | 89.5 (84.9–92.0) | 89.1 (85.0–91.3) | 90.3 (82.0–93.3) | 0.44 |
| PLT [× 109/L, M(Q)] | 55.0 (27.5–96.0) | 64.0 (41.0–113.5) | 24.0 (20.0–31.5) | < 0.0001 |
| TnI [ng/ml, M(Q), | 0.25 (0.10–1.10)( | 0.19 (0.08–0.52) ( | 2.30 (0.73–7.00)( | < 0.0001 |
| LDH [U/L, M(Q)] | 942.0 (459.8–1736.5) | 806.0 (393.5–942) | 2397.0 (1375.0–2397.0) | < 0.0001 |
| ALT [U/L, M(Q)] | 231 (72.3–1087.8) | 125 (64–456.5) | 2995 (426.5–4296) | < 0.0001 |
| AST [U/L, M(Q)] | 379.5 (122.2–1354.2) | 270 (94.5–685) | 3533 (920–3860.5) | < 0.0001 |
| TBIL [μmol/L, M(Q)] | 33.1 (21.7–61.5) | 28 (20.2–42) | 107.7 (60.9–146.2) | < 0.0001 |
| DBIL [μmol/L, M(Q)] | 16 (9.4–28.9) | 12.5 (8.7–19.3) | 50.2 (32.4–52) | < 0.0001 |
| ALB [g/L, M(Q)] | 37.6 (35.2–40.9) | 37.6 (35.1–41.3) | 36.9 (35–40.7) | 0.503 |
| Cr [μmol/L, M(Q)] | 145.5 (94.8–196.8) | 136 (88.1–175.9) | 237 (116.4–440.4) | 0.001 |
| BUN [mmol/L, M(Q)] | 8.1 (6.3–9.9) | 8.1 (6.1–9.6) | 8.8 (6.5–16.2) | 0.037 |
| CK [U/L, M(Q)] | 3412 (1588.3–6140.5) | 2852 (1441.6–5723) | 8850 (2327.7–35,237) | 0.008 |
| TT [s, M(Q)] | 28.9 (18.7–37.8) | 23.8 (17.9–37.8) | 51 (29–56.7) | 0.002 |
| PT [s, M(Q)] | 22.8 (16.4–43.2) | 19.2 (15.8–26.5) | 63.2 (39.6–93.2) | < 0.0001 |
| APTT [s, M(Q)] | 58.2 (37.4–96.7) | 50.1 (34.8–75.8) | 96.7 (61.1–125.9) | < 0.0001 |
| Fib [g/L, M(Q)] | 1.7 (1.12–2.04) | 1.80 (1.48–2.13) | 1.07 (0.59–1.42) | < 0.0001 |
| D-D [μg/ml, M(Q), | 3.16 (1.09–6.65)( | 2.89 (1.07–8.52)( | 4.45 (1.76–5.93)( | 0.435 |
| K+ [mmol/L, M(Q)] | 3.4 (3.1–3.6) | 3.4 (3.1–3.5) | 3.6 (3.1–3.6) | 0.204 |
| Na+ [mmol/L, M(Q)] | 137.8 (134.4–140.3) | 137.8 (134.8–140.5) | 135.9 (133.1–139.2) | 0.112 |
| Cl− [mmol/L, M(Q) | 103.5 (99.7–106)( | 104 (101–106)( | 100.1 (99.0–104.8)( | 0.27 |
| Ca2+ [mmol/L, M(Q), | 1.83 (1.12–2.04)( | 1.91 (1.16–2.09)( | 1.30 (1.04–1.75)( | 0.012 |
| Glu [mmol/L, M(Q)] | 8.57 (5.98–9.36) | 8.77 (6.05–9.59) | 7.57 (3.45–8.14) | 0.055 |
| AGI [n] | < 0.0001 | |||
| Ia,b,c | 41 | 39 | 2 | |
| IId,e | 37 | 25 | 12 | |
| IIIf | 8 | 3 | 5 | |
| IV | 4 | 2 | 2 |
na represents the missing values of HCO3−; the missing rates between the above two groups is P = 0.281; nb represents the missing values of TnI; the missing rates between the above two groups is p = 0.802; nc represents the missing values of D-D; the missing rates between the above two groups is P = 0.597; nd represents the missing values of Cl−; the missing rates between the above two groups is P = 0.971; ne represents the missing values of Ca2+, the missing rates between the above two groups is P = 0.842; aGrade I compared with grade II, P = 0.002; bGrade I compared with grade III, P = 0.001; cGrade I compared with grade IV, P = 0.034; dGrade II compared with grade III, P = 0.226; eGrade II compared with grade IV, P = 0.596; f Grade III compared with grade IV, P = 1. T Temperature, MAP Mean Arterial Pressure, RR Respiratory Rate, HR Heart Rate, GCS Glasgow Coma Scale, SaO2 Oxygen Saturation, Lac Lactate, Hb Haemoglobin, WBC White Blood Cell count, N Neutrophils, PLT Platelets, TnI Troponin I, LDH Lactate dehydrogenase, ALT Alanine Transaminase, AST Aspartate Transaminase, TBIL Total Bilirubin, DBIL Direct Bilirubin, ALB Albumin, Cr Creatinine, BUN Blood Urea Nitrogen, CK Creatine Kinase, TT Thrombin Time, PT Prothrombin Time, APTT Activated part of the Prothrombin Time, Fib Fibrinogen, D-D D-dimer, FDP Fibrin degradation products, K+ Potassium, Na+ Sodium, Cl- Chlorine, Ca2+ Calcium, Glu Glucose, AGI Acute Gastrointestinal Injury
The screened parameters for EHSS by AUC
| Parameters | AUC (95%CI) | Sensitivity (%) | Specificity (%) | Optimal cut-off value | |
|---|---|---|---|---|---|
| T [°C, M(Q)] | 0.737 (0.629–0.846) | 95.2 | 46.4 | 40.1 | < 0.0001 |
| GCS [score, M(Q)] | 0.807 (0.714–0.901) | 72.5 | 81.0 | 4.5 | < 0.0001 |
| PH [M(Q)] | 0.883 (0.791–0.974) | 91.3 | 85.7 | 7.28 | < 0.0001 |
| Lac [mmol/L, M(Q)] | 0.87 (0.771–0.97) | 76.2 | 95.7 | 8.75 | < 0.0001 |
| PLT [×109/L, M(Q)] | 0.844 (0.757–0.93) | 69.6 | 95.2 | 47.5 | < 0.0001 |
| PT [s, M(Q)] | 0.876 (0.781–0.971) | 76.2 | 94.2 | 47.1 | < 0.0001 |
| APTT [s, M(Q)] | 0.764 (0.663–0.866) | 61.9 | 82.6 | 88.4 | < 0.0001 |
| Fib [g/L, M(Q)] | 0.823 (0.716–0.931) | 78.3 | 81.0 | 1.43 | < 0.0001 |
| TnI [ng/ml, M(Q)] | 0.841 (0.709–0.973) | 78.6 | 83.3 | 0.785 | < 0.0001 |
| LDH [U/L, M(Q)] | 0.895 (0.821–0.0.969) | 95.2 | 81.2 | 1049 | < 0.0001 |
| ALT [U/L, M(Q)] | 0.832 (0.723–0.942) | 71.4 | 92.8 | 1407.5 | < 0.0001 |
| AST [U/L, M(Q)] | 0.867 (0.782–0.951) | 76.2 | 89.9 | 1312.0 | < 0.0001 |
| TBIL [μmol/L, M(Q)] | 0.887 (0.797–0.976) | 81.0 | 89.9 | 60.15 | < 0.0001 |
| Cr [μmol/L, M(Q)] | 0.739 (0.604–0.875) | 71.4 | 72.5 | 170 | < 0.0001 |
EHSS Exertional Heat Stroke Score, AUC area under the receiver operating characteristic curve, T Temperature, GCS Glasgow Coma Scale, Lac Lactate, PLT Platelets, PT Prothrombin Time, APTT Activated part of the Prothrombin Time, Fib Fibrinogen, TnI Troponin I, LDH Lactate dehydrogenase, ALT Alanine Transaminase, AST Aspartate Transaminase, TBIL Total Bilirubin, Cr Creatinine
Fig. 1The AUCs of various parameters for EHSS
Fig. 2Mortality at different intervals of EHSS parameters
Detailed contents of Exertional Heat Stroke Score (EHSS)
| Parameters | 0 point | 1 point | 2 points | 3 points | 4 points |
|---|---|---|---|---|---|
| T(°C) | 39–39.9 | 40–40.9 | 41–41.5 | 41.6–41.9 | ≥42 |
| GCS | 15 | 10–14 | 7–9 | 5–6 | < 5 |
| pH | ≥7.35 | 7.30–7.34 | 7.25–7.29 | 7.20–7.24 | < 7.20 |
| Lac (mmol/L) | ≤2.0 | 2.1–4.0 | 4.1–8.0 | 8.1–10.0 | > 10 |
| PLT (×109/L) | ≥100 | 50–99 | 40–49 | 30–39 | < 30 |
| PT (s) | < 13 | 13–18 | 18.1–45 | 45.1–60 | > 60 |
| Fib (g/L) | >2.00 | 1.50–2.00 | 1.00–1.49 | 0.50–0.99 | < 0.50 |
| TnI (ng/ml) | ≤0.10 | 0.11–0.59 | 0.60–1.00 | 1.01–1.49 | ≥1.5 |
| AST (U/L) | ≤200 | 201–1000 | 1001–2000 | 2001–3000 | > 3000 |
| TBIL (μmol/L) | < 20 | 20–50 | 51–100 | 101–150 | > 150 |
| Cr (μmol/L) | < 80 | 80–160 | 161–250 | 251–400 | > 400 |
| AGI | I | II, III, IV |
T Temperature, GCS Glasgow Coma Scale, Lac Lactate, PLT Platelets, PT Prothrombin Time, APTT Activated part of the Prothrombin Time, Fib Fibrinogen, TnI Troponin I, LDH Lactate dehydrogenase, ALT Alanine Transaminase, AST Aspartate Transaminase, TBIL Total Bilirubin, Cr Creatinine, AGI Acute Gastrointestinal Injury
Fig. 3The AUC of each parameter for EHSS was calculated using the EHSS verification database
The APACHE II, SOFA and EHSS scores of EHS patients in EHSS verification group
| Scores | Total ( | Survival group ( | Non-survival group ( | |
|---|---|---|---|---|
| APACHEII [score, ( | 21.2 ± 7.3 | 18.9 ± 5.9 | 29.1 ± 6.4 | < 0.0001 |
| SOFA [score, M(Q)] | 8 (4.3–12.0) | 7.0 (4.0–10.0) | 13.5 (11.8–15.0) | < 0.0001 |
| EHSS [score, M(Q)] | 15.0 (10.0–23.8) | 12.0 (8.8–16.2) | 29.5 (26.0–32.0) | < 0.0001 |
SOFA Sequential Organ Failure Assessment score, APACHE II Acute Physiology and Chronic Health Evaluation II score, EHSS Exertional Heat Stroke Score
Fig. 4The AUCs of APACHE II, SOFA and EHSS
The mortality at different score intervals of EHSS
| Scores | Total( | Survival group( | Non-survival group( | Mortality(%) |
|---|---|---|---|---|
| 0-5 | 1 | 1 | 0 | 0 |
| 6-10 | 22 | 22 | 0 | 0 |
| 11-15 | 19 | 19 | 0 | 0 |
| 16-20 | 13 | 13 | 0 | 0 |
| 21-25 | 6 | 4 | 2 | 33.3 |
| 26-30 | 9 | 1 | 8 | 88.9 |
| 31-35 | 8 | 2 | 6 | 75 |
| 36-40 | 1 | 0 | 1 | 100 |
| 41-47 | 1 | 0 | 1 | 100 |